Meclizine Hydrochloride — Active Pharmaceutical Ingredient

Meclizine Hydrochloride is an active pharmaceutical ingredient found in 2 FDA-approved drug products. Forms: TABLET, TABLET, CHEWABLE. Routes: ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Meclizine Hydrochloride (2 brand names, 2 dosage forms, 1 route)

Available dosage forms: TABLET, TABLET, CHEWABLE.

Routes of administration: ORAL.

Brand Names

  • ANTIVERT
  • MECLIZINE HYDROCHLORIDE

Indications and Usage

Meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.

Contraindications

Meclizine hydrochloride is contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see Adverse Reactions (6)and Description (11)].

Adverse Reactions

The following adverse reactions associated with the use of meclizine hydrochloride were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported.

Mechanism of Action

The precise mechanism by which meclizine exerts its therapeutic effect is unknown but is presumed to involve antagonism of the histamine H1 receptor.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.